Aesthetic Injectable Market Introduction and Overview
According to SPER market research, ‘Aesthetic Injectable Market Size- By Type, By Application, By End-User – Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Aesthetic Injectable Market is predicted to reach 39.72 billion by 2034 with a CAGR of 12.39%.
Aesthetic injectables have revolutionized cosmetic dermatology and plastic surgery by offering minimally invasive methods of facial rejuvenation and contouring. Botulinum toxin (Botox, Dysport, and Xeomin) and dermal fillers are the most often used injectables. They are often used to eliminate wrinkles, restore lost volume, increase facial symmetry, and improve skin texture without the need for surgery. With rising consumer awareness and technological advancements, the cosmetic injectable market has expanded dramatically in recent years.
Restraints: The global aesthetic injectable market has several obstacles that hinder its growth and usage. The strict regulatory system that oversees the authorization and distribution of injectables is a significant barrier. Stringent safety and efficacy criteria are enforced by regulatory authorities such as the United States Food and Drug Administration and the European Medicines Agency, which can lead to product delays and higher manufacturing costs.
Scope of the Report:
Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered
By Type, By Application, By End-User.
Regions covered
North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.
Companies Covered
Ipsen Pharma, AbbVie Inc., Merz GmbH and Co. KGaA, Galderma, Prollenium Medical Technologies Inc., Suneva Medical Inc., Sinclair Pharma, Medytox Inc., Revance Therapeutics Inc.
Aesthetic Injectable Market Segmentation:
By Type: Based on the Type, Global Aesthetic Injectable Market is segmented as; Collagen, Hyaluronic Acid, Botulinum Toxin, Polylactic Acid, Polymethyl-Methacrylate Microspheres (PMMA), Calcium Hydroxylapatite, Fat Injections, Others.
By Application: Based on the Application, Global Aesthetic Injectable Market is segmented as; Facelift, Facial Line Correction, Acne Scar Treatment, Wrinkle Reduction, Lip Enhancement, Lipoatrophy Treatment, Others.
By End-User: Based on the End-User, Global Aesthetic Injectable Market is segmented as; Hospitals And Ambulatory Surgery Centres, Dermatology And Cosmetic Clinics, Others.
By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa
- 1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
- 2. Research Methodology
- 2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
- 2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
- 3. Executive Summary
- 4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
- 5. Market variable and outlook
- 5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
- 5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
- 5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat Map Analysis
- 6. Competitive Landscape
- 6.1. Global Aesthetic Injectable Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Aesthetic Injectable Market
- 7. Global Aesthetic Injectable Market, By Type 2021-2034 (USD Million)
- 7.1. Collagen
- 7.2. Hyaluronic Acid
- 7.3. Botulinum Toxin
- 7.4. Polylactic Acid
- 7.5. Polymethyl-methacrylate Microspheres (PMMA)
- 7.6. Calcium Hydroxylapatite
- 7.7. Fat Injections
- 7.8. Others
- 8. Global Aesthetic Injectable Market, By Application 2021-2034 (USD Million)
- 8.1. Facelift
- 8.2. Facial Line Correction
- 8.3. Acne Scar Treatment
- 8.4. Wrinkle Reduction
- 8.5. Lip Enhancement
- 8.6. Lipoatrophy Treatment
- 8.7. Others
- 9. Global Spinal Implants and Devices Market, By End-User 2021-2034 (USD Million)
- 9.1. Hospitals & Ambulatory Surgery Centers
- 9.2. Dermatology & Cosmetic Clinics
- 9.3. Others
- 10. Global Aesthetic Injectable Market 2021-2034 (USD Million)
- 10.1. Global Aesthetic Injectable Market Size and Market Share
- 11. Global Aesthetic Injectable Market, By Region, 2021-2034 (USD Million)
- 11.1. Asia-Pacific
- 11.1.1. Australia
- 11.1.2. China
- 11.1.3. India
- 11.1.4. Japan
- 11.1.5. South Korea
- 11.1.6. Rest of Asia-Pacific
- 11.2. Europe
- 11.2.1. France
- 11.2.2. Germany
- 11.2.3. Italy
- 11.2.4. Spain
- 11.2.5. United Kingdom
- 11.2.6. Rest of Europe
- 11.3. Middle East and Africa
- 11.3.1. Kingdom of Saudi Arabia
- 11.3.2. United Arab Emirates
- 11.3.3. Qatar
- 11.3.4. South Africa
- 11.3.5. Egypt
- 11.3.6. Morocco
- 11.3.7. Nigeria
- 11.3.8. Rest of Middle-East and Africa
- 11.4. North America
- 11.4.1. Canada
- 11.4.2. Mexico
- 11.4.3. United States
- 11.5. Latin America
- 11.5.1. Argentina
- 11.5.2. Brazil
- 11.5.3. Rest of Latin America
- 12. Company Profile
- 12.1. Ipsen Pharma
- 12.1.1. Company details
- 12.1.2. Financial outlook
- 12.1.3. Product summary
- 12.1.4. Recent developments
- 12.2. AbbVie Inc.
- 12.2.1. Company details
- 12.2.2. Financial outlook
- 12.2.3. Product summary
- 12.2.4. Recent developments
- 12.3. Merz GmbH and Co. KGaA
- 12.3.1. Company details
- 12.3.2. Financial outlook
- 12.3.3. Product summary
- 12.3.4. Recent developments
- 12.4. Galderma
- 12.4.1. Company details
- 12.4.2. Financial outlook
- 12.4.3. Product summary
- 12.4.4. Recent developments
- 12.5. Prollenium Medical Technologies Inc.
- 12.5.1. Company details
- 12.5.2. Financial outlook
- 12.5.3. Product summary
- 12.5.4. Recent developments
- 12.6. Suneva Medical Inc.
- 12.6.1. Company details
- 12.6.2. Financial outlook
- 12.6.3. Product summary
- 12.6.4. Recent developments
- 12.7. Sinclair Pharma
- 12.7.1. Company details
- 12.7.2. Financial outlook
- 12.7.3. Product summary
- 12.7.4. Recent developments
- 12.8. Medytox Inc.
- 12.8.1. Company details
- 12.8.2. Financial outlook
- 12.8.3. Product summary
- 12.8.4. Recent developments
- 12.9. Revance Therapeutics Inc.
- 12.9.1. Company details
- 12.9.2. Financial outlook
- 12.9.3. Product summary
- 12.9.4. Recent developments
- 12.10. Others
- 13. Conclusion
- 14. List of Abbreviations
- 15. Reference Links
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook